Please upgrade your browser.
Abstracts in genitourinary cancers, including: Changes in treatment patterns among patients receiving at least two targeted therapies for metastatic renal cell carcinoma (mRCC) in the US...
An aggressive form of kidney cancer subsides in mice when researchers block the metabolism of an amino acid called glutamine, a new study shows.
Gene Evaluation of DNA expression from snap-frozen renal cell cancer tissue from 5 patients with locally advanced non-metastatic tumors, submitted to nephrectomy after being treated with 2 cycles of neoadjuvant Sunitinib...
Supported by Kidney Cancer Association.Matthew T. Campbell, MD The University of Texas MD Anderson Cancer Center “Enhancing therapeutic efficacy in metastatic renal cell carcinoma by combining immune check point blockade with cryoablation”
Ethical Issues in the Management of RCC, including informed consent, disclosure of physician experience, and more.
We present an unusual case of metastatic renal cell carcinoma (RCC) mimicking diverticulitis in a 76-year-old man with a 16-year history of chronic lymphocytic leukaemia (CLL) and a 2 cm left renal mass.
Seven new agents have been approved for renal cell over a relatively short period of time. That has made it difficult to determine which drugs should be used for first, says Hutson.
Willie sells her scarves for $20 each and has raised more than $45,000 for the Kidney Cancer Association since beginning to knit.
UNM Cancer Center enrolls first patient in phase 3 international clinical trial for kidney cancer vaccine
The phase 3 trial at the UNM Cancer Center tests a promising new approach: it uses a person's own kidney cancer cells to make a vaccine tailored to kill those cells.
|Powered by NeonCRM|